Abstract
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system which leads to demyelination and neurodegeneration. The T and B cells, the body’s immune cells, start attacking the brain and spinal cord, leading to a variety of symptoms. Alemtuzumab is a recently approved disease-modifying therapy that has been shown to have a very high impact on MS. However, it has many potentially life-threatening side effects which patients are often not aware of. For treatments as effective and risky as Alemtuzumab, patients who are considering it must be well-informed on the process and the potential side effects. Patient education is vital to equip patients with knowledge on their disease and treatment, and has shown to be successful in improving the management of chronic diseases and increasing medication adherence. Unfortunately, the language used is often too complex and at a higher reading level than average patients can comprehend, and available resources such as pamphlets and websites are often disorganized. This research proposes a radically different approach to patient education, using less formal channels such as a mobile application to improve health literacy, using LEMTRADA® (Alemtuzumab) as an example. MS patients were involved in a co-design process to produce a series of user-friendly, intuitive and interactive graphical interfaces which propose plain language, illustrations, animations, audio and Augmented Reality components that aim to enhance patients’ knowledge retention and recall. Finally, nine MS patients along with a senior MS nurse tested the mobile application and answered a usability questionnaire that aimed to compare the delivery of information with typical websites and pamphlets. Results suggested this approach to be highly user-friendly and engaging, improving patients’ understanding of medical information considerably. This research illustrates more engaging channels to communicate with MS patients in order to enhance health literacy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alsaffar H, Wilson L, Kamdar DP et al (2016) Informed consent: do information pamphlets improve post-operative risk-recall in patients undergoing total thyroidectomy: prospective randomized control study. J Otolaryngol Head Neck Surg 45:14. https://doi.org/10.1186/s40463-016-0127-5
Blackwell RW née, Lowton K, Robert G et al (2017) Using experience-based co-design with older patients, their families and staff to improve palliative care experiences in the emergency department: a reflective critique on the process and outcomes. Int J Nurs Stud 68:83–94. https://doi.org/10.1016/j.ijnurstu.2017.01.002
Brownlee WJ, Hardy TA, Fazekas F, Miller DH (2017) Diagnosis of multiple sclerosis: progress and challenges. Lancet 389:1336–1346. https://doi.org/10.1016/S0140-6736(16)30959-X
Bui D, Nakamura C, Bray BE, Zeng-Treitler Q (2012) Automated illustration of patients instructions. AMIA Annu Symp Proc AMIA Symp 2012:1158–1167
Caon C, Namey M, Meyer C et al (2015) Prevention and management of infusion-associated reactions in the comparison of Alemtuzumab and Rebif® efficacy in multiple sclerosis (CARE-MS) program. Int J MS Care 17:191–198. https://doi.org/10.7224/1537-2073.2014-030
Carroll JK, Moorhead A, Bond R et al (2017) Who uses mobile phone health apps and does use matter? A secondary data analytics approach. J Med Internet Res 19:e125. https://doi.org/10.2196/jmir.5604
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. https://doi.org/10.1016/S0140-6736(08)61620-7
Daniali SS, Shahnazi H, Kazemi S, Marzbani E (2016) The effect of educational intervention on knowledge and self-efficacy for pain control in patients with multiple sclerosis. Mater Socio Med 28:283–287. https://doi.org/10.5455/msm.2016.28.283-287
Dolati S, Babaloo Z, Jadidi-Niaragh F et al (2017) Multiple sclerosis: therapeutic applications of advancing drug delivery systems. Biomed Pharmacother 86:343–353. https://doi.org/10.1016/j.biopha.2016.12.010
DrBarrySinger (2010) The immune attack – multiple sclerosis [video online]. https://www.youtube.com/watch?v=TwqqLhmhonI&t=63s. Access 16 Aug 2018
Eloranta S, Katajisto J, Leino-Kilpi H (2016) Orthopaedic patient education practice. Int J Orthop Trauma Nurs 21:39–48. https://doi.org/10.1016/j.ijotn.2015.08.002
Hadden KB, Hart JK, Lalla NJ, Prince LY (2017) Systematically addressing hospital patient education. J Hosp Librariansh 17:113–124. https://doi.org/10.1080/15323269.2017.1291033
Hill B, Perri-Moore S, Kuang J et al (2016) Automated pictographic illustration of discharge instructions with Glyph: impact on patient recall and satisfaction. J Am Med Inform Assoc 23:1136–1142. https://doi.org/10.1093/jamia/ocw019
Lemtrada (2018) Relapsing MS infusion treatment | LEMTRADA® (alemtuzumab). https://www.lemtrada.com/. Accessed 16 Aug 2018
Lopez-Fernandez O, Kuss DJ, Romo L et al (2017) Self-reported dependence on mobile phones in young adults: a European cross-cultural empirical survey. J Behav Addict 6:168–177. https://doi.org/10.1556/2006.6.2017.020
McEwan L, Caon C, Chieffe C et al (2016) Best practices in Alemtuzumab administration. J Infus Nurs 39:93–104. https://doi.org/10.1097/NAN.0000000000000127
Medscape Campath, Lemtrada (alemtuzumab) dosing, indications, interactions, adverse effects, and more. https://reference.medscape.com/drug/campath-lemtrada-alemtuzumab-342240#4. Accessed 16 Aug 2018
Morgan ER, Laing K, McCarthy J et al (2015) Using tablet-based technology in patient education about systemic therapy options for early-stage breast cancer: a pilot study. Curr Oncol 22:e364–e369. https://doi.org/10.3747/co.22.2476
MS Society Disease modifying therapies | Multiple Sclerosis Society UK. https://www.mssociety.org.uk/about-ms/treatments-and-therapies/disease-modifying-therapies. Accessed 16 Aug 2018
Pecorelli N, Fiore JF, Kaneva P et al (2018) An app for patient education and self-audit within an enhanced recovery program for bowel surgery: a pilot study assessing validity and usability. Surg Endosc 32:2263–2273. https://doi.org/10.1007/s00464-017-5920-3
Quesenberry AC (2017) Plain language for patient education. J Consum Health Internet 21:209–215. https://doi.org/10.1080/15398285.2017.1311611
Rath L, Vijiaratnam N, Skibina O (2017) Assessing understanding of individual risk and symptoms of progressive multifocal leukoencephalopathy in patients prescribed natalizumab for multiple sclerosis. Intern Med J 47:194–199. https://doi.org/10.1111/imj.13318
Sanaeinasab H, Saffari M, Hashempour M et al (2017) Effect of a transactional model education program on coping effectiveness in women with multiple sclerosis. Brain Behav 7:e00810. https://doi.org/10.1002/brb3.810
Sium A, Giuliani M, Papadakos J (2017) The persistence of the pamphlet: on the continued relevance of the health information pamphlet in the digital age. J Cancer Educ 32:483–486. https://doi.org/10.1007/s13187-015-0948-3
Statista Number of mobile phone users worldwide 2015–2020 | Statista. https://www.statista.com/statistics/274774/forecast-of-mobile-phone-users-worldwide/. Accessed 11 Aug 2018
Suhling H, Rademacher J, Zinowsky I et al (2014) Conventional vs. tablet computer-based patient education following lung transplantation – a randomized controlled trial. PLoS One 9:e90828. https://doi.org/10.1371/journal.pone.0090828
Thompson AJ, Baranzini SE, Geurts J et al (2018) Multiple sclerosis. Lancet 391:1622–1636. https://doi.org/10.1016/S0140-6736(18)30481-1
Trinh N, Novice K, Lekakh O et al (2014) Use of a brief educational video administered by a portable video device to improve skin cancer knowledge in the outpatient transplant population. Dermatol Surg 40:1233–1239. https://doi.org/10.1097/DSS.0000000000000148
Zanetti-Yabur A, Rizzo A, Hayde N et al (2017) Exploring the usage of a mobile phone application in transplanted patients to encourage medication compliance and education. Am J Surg 214:743–747. https://doi.org/10.1016/j.amjsurg.2017.01.026
Zimmer A, Bläuer C, Coslovsky M et al (2015) Optimizing treatment initiation: effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction. Mult Scler Relat Disord 4:444–450. https://doi.org/10.1016/j.msard.2015.06.010
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Azman, A., Poyade, M., Overell, J. (2019). Towards a More User-Friendly Medication Information Delivery to People Living with Multiple Sclerosis: A Case Study with Alemtuzumab. In: Rea, P. (eds) Biomedical Visualisation . Advances in Experimental Medicine and Biology, vol 1120. Springer, Cham. https://doi.org/10.1007/978-3-030-06070-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-06070-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-06069-5
Online ISBN: 978-3-030-06070-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)